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immune responses converge to protect the host against fun-
gal infections (reviewed in Romani15). Intact epithelia and en-
dothelia, microbial antagonism, and antimicrobial peptides 
provide the very first line of defense against fungal infections. 
Additionally,  professional  phagocytic  cells  (neutrophils, 
monocytes, macrophages, and dendritic cells [DCs]) reduce 
fungal burden by inducing oxidative and non-  oxidative kill-
ing of fungi and by restricting fungal growth and infectivity. 
Nonetheless, localized T cell–mediated immunity (CMI), 
specifically T-  helper (Th)1-  mediated responses, remains the 
major defense mechanism against VC.16,17 Systemic T-  cell re-
sponses generated following the induction of VC18
–20 fail to 
provide significant protection against subsequent localized 
C. albicans infection in mice with experimental VC.17 Dele-
tion of systemic CD4+ or CD8+ T cells does not significantly 
influence the kinetics of VC in mice.18 Furthermore, absolute 
numbers of vaginal, but not peripheral, T cells undergo signif-
icant changes during experimental VC in mice.12 Previously, it 
has been shown that while CD3+ T cells from draining lymph 
node and vaginal mucosa undergo minor activation, expres-
sion of T-  cell activation markers α4-  β7, αM290-  β7, and α4-  β1 
drops during primary or secondary   estrogen-  maintained 
VC.19 In contrast, the expression of mucosal and vascular cell 
adhesion molecule 1 on vaginal tissue cells is upregulated.19 
These findings suggest that despite upregulated expression of 
several T-  cell activation markers during VC, lack of expres-
sion of corresponding ligands limits the capacity of CMI to 
deal with C. albicans vaginal infection. Numerous studies 
have suggested that CD28 /   B7 (CD80 or CD86)-  dependent 
T-  cell costimulation is essential for induction and mainte-
V
aginal candidiasis (VC) is now recognized as a ma-
jor  health  problem  for  women  of  childbearing  age 
worldwide.1,2 The majority of genitourinary tract fungal in-
fections are caused by Candida albicans3; VC cases owing to C. 
glabrata, C. tropicalis, and C. kruzi are also on the rise.4,5 The 
majority of women who experience sporadic episodes of VC 
are otherwise healthy. However, around 10% of women are at 
increased risk of VC owing to compromised immunity, antibi-
otic overuse, and increased estrogen concentration in the re-
productive tract environment.1
–3,6 Estrogen predisposes to VC 
by several proposed mechanisms, including the enhancement 
of the pathogenic potential of Candida species and the sup-
pression of host immunity.7
–11 Induction of a pseudoestrous 
state by estrogen is routinely used to establish experimental 
persistent C. albicans vaginal infection in rodents.10,12
–14 Fur-
thermore, estrogen, administered on a weekly basis, can in-
duce persistent VC in naive non–germ-  free Balb /   c mice.13
It is well established now that both innate and acquired 
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characteristic of candidiasis, pooled, and trimmed into about 
5 mm pieces. About one-  fifth of trimmed tissue was homog-
enized in 10 mL PBS in a sterile glass homogenizer; the rest 
was saved for isolation of vaginal lymphocytes. Spleen and 
draining lymph node homogenates were prepared by press-
ing the tissue through a sterile stainless steel mesh screen into 
10 mL PBS under aseptic conditions. Separate serial 10-  fold 
dilutions (10
–1, 10
–2, 10
–3) of homogenates were prepared and 
aliquots of 1 mL /   dilution were poured into separate culture 
plates containing 10 mL premelted SDA supplemented with 
chloramphenicol; each sample dilution was cultured in tripli-
cate. Plates were left to solidify at room temperature and then 
cultured for 48 hours at 37°C; colonies were counted and ex-
pressed as the mean   colony-  forming unit (CFU) per mouse ± 
standard deviation.
Isolation of Lymphocytes
Isolation of vaginal lymphocytes was performed as described 
previously.12 Briefly, five to six mice were sacrificed per group 
per time point. Vaginas were isolated, flushed with RPMI-   
1640 media (Sigma Chemicals, St. Louis, MO), opened up 
longitudinally, and cut into 5 mm pieces. Tissue pieces were 
placed in 50 mL warm PBS containing 1 mM ethylenedi-
aminetetraacetic acid and 1 mM dithiothreitol (DTT). The 
mixture was stirred for 30 minutes at 37°C; cell suspensions 
were centrifuged for 5 minutes at 250g. Splenocytes were pre-
pared by pressing intact spleens through sterile stainless steel 
mesh screens into 5 mL RPMI-  1640; cells were then collected 
by centrifugation. Pellets were washed once and resuspended 
in RPMI-  1640. Lymphocytes were counted using a hemocy-
tometer chamber (Superior, Germany), and viability was de-
termined by trypan blue exclusion.
Antibodies and Flow Cytometric Analysis
Antibodies used in this study included fluorescein isothiocya-
nate (FITC)-  labelled rat antimouse CD3 (clone KT3), phyco-
erythrin (PE)-  labelled rat antimouse CD4 (clone YTS191.1); 
FITC-  labelled rat antimouse CD8α (clone KT15); PE-  labelled   
hamster antimouse CD28 (clone 37.51.1); PE-  Cy5-  labelled ham-
ster antimouse CD69 (clone H1.2F3); and PE-  labelled rat anti-
mouse CD25 (clone PC61.5.3). These reagents and the Ig 
  isotype-  matched controls were all purchased from Serotec 
Ltd. (Oxford, UK). An FITC-  labelled rat antimouse   CTLA-  4 
(CD152) (clone 63828) antibody was purchased from R&D 
Systems  (Emeryville,  CA). About 106  viable  cells  in  100 
μL PBS were reacted with titrated concentrations of FITC- 
  labelled CD3 and PE-  labelled CD4 for dual-  colour analysis 
or with PE-  labelled CD25, CD28, or CD69 or FITC-  labelled 
nance of protective immunity against fungal infections.20
–22 
Additionally, CD152 engagement with B7 (CD80 or CD86) 
on antigen presenting cells (APCs) has been shown to sub-
due localized Th1-  mediated immune response.20,23 To further 
investigate this issue, the pattern of expression of several T- 
cell activation markers (CD25, CD28, CD69, and CTLA-  4 
or CD152) was evaluated on vaginal and peripheral T cells at 
several time points during   estrogen-  maintained experimental 
VC in mice. The pattern of expression of these markers, at 
each time point, was correlated with tissue fungal burden and 
lymphocyte numbers.
Materials and Methods
Mice and Microorganisms
Adult 12-   to 14-  week-  old non-  pregnant Balb /   c female mice 
raised under clean but non–germ-  free conditions at the 
Hashemite University vivarium were used throughout the 
study.13 Animal handling was in accordance with institution-
ally drafted guidelines. American Type Culture Collection 
C. albicans 36083 strain, kindly provided by Dr. Mahmoud 
Ghannoum (Center for Medical Mycology Laboratory, Uni-
versity Hospital of Cleveland, OH), was used throughout the 
study. The fungus was maintained on Sabouraud dextrose 
agar (SDA) (HiMedia, Mumbai, India) slants supplemented 
with chloramphenicol at 50 mg /   L at 4°C and subcultured at 
3-  month intervals.
Induction of Experimental VC
Methods of induction of   estrogen-  dependent experimental 
VC are published elsewhere.12 Briefly, mice were injected sub-
cutaneously with 0.5 mg estradiol valerate diluted in 0.1 mL 
sesame oil (Schering AG, Germany) 3 days prior to C. albicans 
inoculation and at weekly intervals thereafter. Each mouse re-
ceived a single 100 μL intravaginal inoculum of 2 × 107 viable 
  stationary-  phase blastoconidia grown overnight in trypton 
soya broth (ADSA Micro, Spain). Age-   and sex-  matched mice 
that received either a single intravaginal injection of 0.1 mL 
autoclaved   phosphate-  buffered saline (PBS) or a single 100 μL 
intravaginal inoculum of 2 × 107 viable   stationary-  phase blas-
toconidia were used as controls.
Evaluation of Tissue (Vagina and Spleen) Fungal 
Burden
Five to six mice per group were sacrificed by cervical disloca-
tion at different time points post–C. albicans inoculation. Va-
ginas were isolated, examined for the presence of white lesions   Al-  Sadeq et al, Vaginal T Lymphocytes  159
(p < .05) higher than those in naive control mice (≈2 × 103 
CFU /   vagina). Vaginal fungal burden in experimental mice 
peaked at day 21 postinfection, reaching 80 × 103 CFU /   va-
gina, and then precipitously dropped to about 17 × 103 CFU /   
vagina (see Figure 1). Splenic fungal burden in experimen-
tal mice, which was detectable only during the first 2 weeks, 
was only slightly higher than that in the spleens (see Figure 
1) of control groups. No detectable fungal burden was de-
tected in draining lymph node homogenates prepared from 
experimental and control mice (data not shown). The mor-
tality  rate  in  the  experimental  group  was  insignificantly 
higher than that in the control groups (data not shown). The 
number of vaginal lymphocytes gradually and significantly 
increased from about 1.5 × 106 cells /   vagina in naive con-
trol mice to > 14 × 106 cells /   vagina in experimental mice at   
day 35 postinfection (Figure 2A). The number of spleen lym-
phocytes also increased from about 60 × 106 cells /   spleen in 
naive mice to > 95 × 106 cells /   spleen at day 14 postinfection, 
which then precipitously dropped to background levels at 
days 28 and 35 postinfection (Figure 2B).
The percentage of CD3+ vaginal T cells isolated from con-
trol mice was > 20%, 25% of which were CD4+ (Figure 3). The 
percentage of CD28+ and CD152+ vaginal T cells in these mice 
was 11% and 29%, respectively; the proportion of vaginal T 
cells expressing CD25 or CD69 was negligible (< 2%). Fol-
lowing the induction of VC, however, the percentage of CD3+ 
vaginal T cells significantly increased to reach about 80% at 
CD8 or CD152 for   single-  colour analysis. Reaction tubes were 
kept on ice for 20 to 25 minutes before fixation with 1 mL 
of 2% paraformaldehyde per sample tube. Flow cytometric 
analysis was done on a Partec PAS flow cytometer (Partec, 
Münster, Germany) using Flowmax software (Partec) for data 
acquisition and analysis. Gating of the target population was 
performed based on lymphocyte physical properties and per-
centage expression of CD3. Cursors were set based on preruns 
of cell samples stained with   isotype-  matched control antibod-
ies. On average, 50,000 events were collected for   single-  colour 
analysis and 70,000 events for   double-  colour analysis. Per-
centage positive staining was computed to the 99% confidence 
level at a logarithmic scale of three decades.
Statistical Analysis
One-  way analysis of variance was employed to determine lev-
els of significance within experimental groups, and the Fisher 
least significant difference test was used to determine the pres-
ence of significant differences between different means.
Results
Consistent with previous studies,12
–14 estrogen was able to 
induce persistent VC in treated C. albicans–infected mice 
throughout the study period (Figure 1). CFU counts /   vagina 
in treated infected mice were consistently and significantly 
Figure  1.  Vaginal  and  splenic  fungal 
burdens  were  evaluated  in    phosphate-   
buffered  saline–treated  control  mice, 
  estrogen-  treated  Candida  albicans– 
infected  experimental  mice,  and  un-
treated C. albicans–infected control mice 
at days 7, 14, 21, 28, and 35 postinfection. 
The data shown represent mean CFU /   tis-
sue ± SD as calculated from three separate 
experiments using five to six mice /   time 
point /   experiment.160  Allergy, Asthma, and Clinical Immunology, Volume 4, Number 4, 2008
of extensive T-  cell proliferation or activation in the spleen fol-
lowing C. albicans colonization. Compared with splenocytes 
isolated from naive control mice, a considerable but insignifi-
cant (p = .113) increase in CD25+ T cells was noted in experi-
mental mice at weeks 4 and 5 postinfection. The pattern of 
expression of CD69 on splenic T cells was similar to that on 
vaginal lymphocytes (see Figure 4B).
Discussion
The findings reported here clearly show that persistent vagi-
nal C. albicans infection results in significant changes in the 
number, phenotypic profile, and state of activation of vaginal 
T cells. Based on the temporal kinetics of vaginal fungal bur-
day 28 postinfection (see Figure 3). At this time point, about 
50% of CD3+ vaginal T cells were CD4+. The proportion of 
CD28+ vaginal T cells isolated from experimental mice signifi-
cantly increased to > 55% at day 28 postinfection (Figure 4A). 
The percentage of CD152+ vaginal T cells jumped from 29% 
in naive mice to 72% in experimental mice at day 28 postin-
fection (p < .001). Although the percentage of vaginal T cells 
positive for CD25 or CD69 did not significantly change dur-
ing the first 3 weeks postinfection compared with that in con-
trol mice (see Figure 4A), a significant (p < .076) increase in 
the percentage of vaginal T cells expressing CD25 was noted 
at week 4 postinfection.
As shown in Figure 4, the greatest week-  to-  week jump in 
the level of expression of CD28 and CD152 on both vaginal 
and splenic T cells occurred between weeks 3 and 4. Com-
pared with 19% CD28+ vaginal T cells at day 21 postinfection, 
CD28+ cells represented > 55% at day 28 postinfection. As for 
CD152+ vaginal T cells, their percentage jumped from 36% at 
day 21 to > 72% at day 28 postinfection. During this phase, the 
proportion of CD3+ and CD3+CD4+ vaginal T cells was about 
80% and 40%, respectively (Figure 3). Interestingly, these 
significant changes were concomitant with the precipitous 
decrease in vaginal fungal burden, as was noted earlier (see 
Figure 1). Furthermore, changes in CD28 and CD152 levels 
of expression corresponded with significant and incremental 
increases in vaginal lymphocyte numbers (Figure 2A). It is 
worth noting that although the percentage of cells express-
ing CD152 was significantly (p < .05) higher than that of cells 
expressing CD28 in the vaginal mucosa and the spleen, dis-
parities in the level of expression of both markers were more 
pronounced in the case of vaginal T cells.
Despite the fact that only minimal splenic C. albicans col-
onization was noted during the first 2 weeks postinfection in 
experimental mice, significant changes in the pattern of ex-
pression of various splenic T-  cell markers were noted during 
the course of the infection. Whereas about 40% of splenic T 
cells isolated from control mice were CD3+ T cells and about 
14% were CD3+CD4+, > 80 of splenic T cells isolated from ex-
perimental mice were CD3+ and > 40% were CD3+CD4+ at 
day 28 postinfection (see Figure 4B). The percentage of CD28+ 
splenic T cells gradually and significantly increased from 43% 
in naive control mice to > 70% on cells isolated at days 28 and 
35 postinfection (see Figure 4B). Additionally, the percentage 
of splenic T cells expressing CD152 increased from 53% in na-
ive mice to 88% in experimental mice at day 28 postinfection 
(see Figure 4B). It is worth noting that the percentage of CD3+, 
CD28+, and CD152+ cells isolated from experimental mice at 
weeks 4 to 5 postinfection was extremely high compared with 
that in naive mice. In other words, the majority of splenocytes 
of experimental mice were T cells; this is perhaps suggestive 
Figure  2.  Absolute  numbers  of  vaginal  (A)  and  splenic  (B)  lympho-
cytes isolated from   phosphate-  buffered saline–treated control mice and 
  estrogen-  treated Candida albicans–infected experimental mice at days 7, 14, 
21, 28, and 35 postinfection. Cell counts were plotted against the time points 
at which cells were harvested. The mean number of lymphocytes /   tissue ± 
SEM was calculated based on data from three separate experiments, five to 
six mice /   time point /   experiment.  Al-  Sadeq et al, Vaginal T Lymphocytes  161
Figure 3. Vaginal lymphocytes isolated 
from   phosphate-  buffered saline–treated 
control mice and from   estrogen-  treated 
Candida albicans–infected experimental 
mice at day 28 postinfection were sepa-
rately pooled from five to six mice and 
stained with anti-  CD3 and anti-  CD4 for 
two-  colour flow cytometric (FCM) anal-
ysis or with anti-  CD28, or anti-  CD69 or 
anti-  CD152 for   single-  colour FCM analy-
sis. The data shown are representative of 
three separate experiments.162  Allergy, Asthma, and Clinical Immunology, Volume 4, Number 4, 2008
study, draining lymph node DCs during VC were reported 
to predominantly express an immunoregulation-  associated 
CD11c+B220+ plasmacytoid phenotype.24 Furthermore, al-
though draining lymph node CD3+ T cells were slightly ac-
tivated during primary and secondary C. albicans infections, 
the numbers of CD3+ T cells expressing α4-  β7, αM290-  β7, 
and α4-  β1 homing markers were reduced.19
During the second or resolution phase, which starts to-
ward the end of week 3, a massive and precipitous decrease in 
vaginal fungal burden occurs concurrently with a significant 
surge in the number of vaginal lymphocytes and a very sig-
nificant increase in the percentage of vaginal T cells express-
ing CD3, CD4, CD25, and CD28. Paradoxically, this phase is 
also marked by the presence of significant numbers of cells 
expressing CD152. Increased presence of T cells expressing 
the stimulatory marker CD28 (and probably those express-
ing CD25) is suggestive of   scaled-  down immunosuppression, 
thus permitting T cells to expand. Once again, engagement 
of CD28-  B7 (CD80 or CD86) mediates a stimulatory sig-
nal, leading to T-  cell activation and release of cytokines or 
immune mediators.21
–23 The paradoxical presence of both 
CD152+ and CD28+ cells during this phase may represent a 
state of competition between these two populations to interact 
with CD80 /   CD86 ligands on vaginal mucosa tissue APCs.
Changes in peripheral (splenic) lymphocyte numbers 
and phenotypic profiles suggest that responses to VC may 
involve a systemic aspect preceding or concurrent with the 
appearance of the localized response. This is consistent with 
the current understanding that CMI at the mucosa level par-
tially derives from the systemic immune circuit.17 Persistent 
upregulation of CD152, subdued number of T-  cell subsets ex-
pressing CD69, and the gradual increase in CD25+ and CD28+ 
splenic T cells being similar to that of vaginal T cells are an 
indication that the spleen, as a peripheral immune compart-
ment, is also subject to   estrogen-  mediated immunosuppres-
sion. As to whether the minimal levels of C. albicans coloniza-
tion noted in the spleen during the early phase of the infection 
(see Figure 1) was responsible for the noted changes in splenic 
cell number and phenotype ican not be readily established. 
However, the capacity of estrogen to alter the immunocompe-
tence of the periphery cannot be overlooked. Several reports 
have suggested that estrogen suppresses the delayed type hy-
persensitivity (DTH) response10 and other innate immune re-
sponses.25,26 Additionally, estrogen was recently shown to re-
duce the number and potential of APCs to present C. albicans 
antigenic peptides to T cells; it was also shown to be capable 
of suppressing T-  cell activity.11 Estrogen treatment can reduce 
the recovery of APCs from the peritoneal cavity and can in-
hibit the production of interleukin (IL)-  12 and   interferon-  γ 
but not IL-  10.11 Whereas estrogen receptor α (ER-  α) defi-
den and the pattern of expression of T-  cell activation markers, 
  estrogen-  maintained persistent VC seems to proceed in two 
sequential phases. During the first phase (first 3 weeks), the 
pathogen seems to overcome whatever resistance it faces from 
the local immune response. This is probably necessary should 
the pathogen be able to establish a persistent state of infection. 
During this phase, the number of vaginal T cells and the ex-
pression of T-  cell activation markers CD25, CD69, and CD28 
are all subdued. This phase is also marked by the presence of a 
dominant T-  cell population expressing CD152 but not CD25 or 
CD28, perhaps indicative of suppressed vaginal T-  cell activity. 
Engagement of CD152-  B7 (CD80 or CD86) was reported to 
mediate inhibitory signals leading to T-  cell anergy, apoptosis, 
or the production of inhibitory Th2 cytokines.23 Additionally, 
T cells can instruct DCs to manifest tolerogenic properties 
via CD152 engagement with B7 on DCs.20 Consistent with the 
possible immunosuppressive tolerogenic state noted in our 
Figure 4. Summary of the mean percentage expression ± SD of CD25, 
CD28, CD69, and CD152 on (A) vaginal and (B) splenic T cells isolated 
from   estrogen-  treated Candida albicans–infected experimental mice at days 
0, 7, 14, 21, 28, and 35 postinfection. Means ± SD were calculated based on 
three separate experiments; at each time point, tissue lymphocytes were iso-
lated from five to six mice and pooled prior to staining and flow cytometric 
  analysis.  Al-  Sadeq et al, Vaginal T Lymphocytes  163
possible role of CD8+ T cells in protection against vaginal candidiasis. 
Clin Exp Immunol 2003;131:26–33.
  13.  Hamad M, Abu-  Elteen KH, Ghaleb M.   Estrogen-  dependent induction 
of vaginal candidiasis in naive mice. Mycoses 2004; 47:304–9.
  14.  Hamad M, Muta’eb E, Abu Shaqra Q, et al. Utility of the   estrogen-   
dependent vaginal candidiasis murine model in evaluating the effi-
cacy of various therapies against vaginal C. albicans infection. Mycoses 
2006;49:104–8.
  15.  Romani L. Immunity to Fungi. In: Kavanagh K, editor. New insights in 
medical mycology. 1st ed. Dordrecht (the Netherlands): Springer Sci-
ence & Business Media; 2007. p. 1–19.
  16.  Fidel PL, Lynch ME, Sobel JD. Effects of pre-  induced   Candida-  specific 
systemic cell-  mediated immunity on experimental vaginal candidiasis. 
Infect Immun 1994;62:1032–8.
  17.  Fidel PL. Immunity to Candida. Oral Dis 2002;8:69–75.
  18.  Fidel PL, Lynch ME, Sobel JD. Circulating CD4 and CD8 T cells have 
little impact on host defense against experimental vaginal candidiasis. 
Infect Immun 1995;63:2403–8.
  19.  Wormley FL, Chaiban J, Fidel PL. Cell adhesion molecule and lympho-
cyte activation marker expression during experimental vaginal candidi-
asis. Infect Immun 2001;69:5072–9.
  20.  Orabona C, Grohmann U, Belladonna ML, et al. CD28 induces immu-
nostimulatory signals in dendritic cells via CD80 and CD86. Nat Im-
munol 2004;5:1103–5.
  21.  Monagnoli C, Bacci A, Bozza S, et al. B7 /   CD28-  dependent CD4+CD25+ 
regulatory T cells are essential components of the   memory-  protective 
immunity to Candida albicans. J Immunol 2002;169:6298–308.
  22.  Wüthrich M, Warner T, Klein SB. CD28 is required for optimal induc-
tion, but not maintenance, of   vaccine-  induced immunity to Blastomyces 
dermatitidis. Infect Immun 2005;73:7436–41.
  23.  Mencacci A, Cenci E, Del Sero G, et al. IL-  10 is required for develop-
ment of protective Th1 responses in IL-  12-  deficient mice upon Candida 
albicans infection. J Immunol 1998;161:6228–37.
  24.  LeBlanc DM, Barousse MM, Fidel PL. Role of dendritic cells in immu-
noregulation during experimental vaginal candidiasis. Infect Immun 
2006;74:3213–21.
  25.  Lambert KC, Curran EM, Judy BM, et al. Estrogen receptor alpha 
(ERalpha) deficiency in macrophages results in increased stimulation 
of CD4+ T cells while 17 beta-  estradiol acts through ERalpha to increase 
IL-  4 and GATA-  3 expression in CD4+ T cells independent of antigen 
presentation. J Immunol 2005;175:5716–23.
  26.  Harairi R, Hamad M, Abu-  Elteen KH. Vaginal candidiasis induces a 
systemic acute phase reactant   protein-  dependent iron-  restrictive envi-
ronment that limits dissemination of the infection. Medimond Interna-
tional Proceedings of the 12th International Congress of Immunology, 
Montreal, Canada 2004;E718C3318:91–95.
  27.   Nalbandian G,   Paharkova-  Vatchkova V, Mao A, et al. The selective es-
trogen receptor modulators, tamoxifen and raloxifene, impair dendritic 
cell differentiation and activation. J Immunol 2005;175:2666–75.
  28.  Kametaka M, Kume A, Okada T, et al. Reduction of CTLL-  2 cytotoxic-
ity by induction of apoptosis with Fas-  estrogen receptor chimera. Can-
cer Sci 2003;94:639–43.
ciency in macrophages was shown to result in increased stim-
ulation of CD4+ T cells,   estradiol-  17β acting through ER-  α was 
shown to increase the synthesis of IL-  4 and GATA -  3 from 
CD4+ T cells.25 The selective ER modulators tamoxifen and 
raloxifene were able to impair DC differentiation and activa-
tion.27 In a Fas-  ER fusion protein chimera system, estrogen 
was able to reduce   apoptosis-  mediated cytotoxic T lympho-
cyte activity.28
In conclusion, the capacity of estrogen to induce persis-
tent VC seems to depend on its capacity to suppress host im-
munity, possibly by upregulating the expression of CD152 on 
vaginal and peripheral T cells. Furthermore, resolution of the 
infection may depend on the ability of T lymphocytes to coun-
ter immunosuppression, possibly by upregulating the expres-
sion of T-  cell activation markers such as CD28 and CD25.
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